Company intelligence / Profile preview

M.H. MediCane

Ownership: Private
Employees: ~50
Development stage: Other

Overview

MediCane Health is an international pharmaceutical company specializing in the research, development, and commercialization of cannabis-based therapies. The company operates a vertically integrated model with R&D facilities in Israel and a large-scale EU-GMP manufacturing site in Portugal. MediCane's clinical pipeline focuses on addressing unmet medical needs in neurology and gastroenterology, with lead programs targeting behavioral symptoms of dementia and inflammatory conditions. By combining pharmaceutical standards with proprietary genetics, the company aims to deliver standardized, evidence-based cannabinoid medicines to global markets.

Therapeutic areas: NeurologyDermatologyGastroenterology
Modalities: Small moleculePlant-derived extract
Industry: Biotech

Drug pipeline

1 asset

medical cannabis oil

Partnerships

NeuraxpharmBol Pharma

Beyond the preview

Go deeper on M.H. MediCane.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on M.H. MediCane.